Successful legalization of psychedelics simply cannot happen without commercialization - but advocacy for psychedelic-assisted therapy has gone from being driven largely by medical academics, philanthropists, and various grassroots enthusiasts, to being dominated by entrepreneurs and investors. Shareholders seem prone to accepting company press releases regarding ethical concerns rather than questioning the approaches being taken by the relevant pharma startups they are stakeholders in. What can supporters of psychedelic therapy effectively do to ensure that healing, safety and accessibility get prioritized over ROI and market control?
Therapeutic use of psychedelics seems a surety in the near future. But what framework for legal, personal use of psychedelics could you see being practical - that is, something that can be realized across the developed world, within our lifetimes?
Successful legalization of psychedelics simply cannot happen without commercialization - but advocacy for psychedelic-assisted therapy has gone from being driven largely by medical academics, philanthropists, and various grassroots enthusiasts, to being dominated by entrepreneurs and investors. Shareholders seem prone to accepting company press releases regarding ethical concerns rather than questioning the approaches being taken by the relevant pharma startups they are stakeholders in. What can supporters of psychedelic therapy effectively do to ensure that healing, safety and accessibility get prioritized over ROI and market control?
Therapeutic use of psychedelics seems a surety in the near future. But what framework for legal, personal use of psychedelics could you see being practical - that is, something that can be realized across the developed world, within our lifetimes?